API response to Pfizer Australia announcement

API response to Pfizer Australia announcement

6 December 2010
ASX Announcement

Australian Pharmaceutical Industries Limited (API) has received notification from Pfizer Australia (Pfizer) that Pfizer intends to cease distributing its prescription medicines through wholesale distributors effective 31 January 2011. API is one of three wholesalers currently distributing Pfizer prescription products. Details of the Pfizer announcement can be found at pfizer.com.au/media


API is analysing the implications of this decision and further information will be provided as soon as practicable.

API contact
Stephen Roche
MD and CEO
(03)87203007

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.